GlassScriptPhysician profile
Michael J Healy
NPI 1619396017
$19,509.45
in general payments reported to CMS, 2019-2025
32 companies · $4,046 in 2025
The $4,046 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.55 · 2020: $75.70 · 2021: $1,292 · 2022: $6,015 · 2023: $5,400 · 2024: $2,630 · 2025: $4,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,681 · Travel and Lodging: $2,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,680.59 |
| Travel and Lodging | $2,395.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,800.43 | 2022-2025 | Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $2,453.79 | 2021-2025 | Mitraclip, Triclip, Xience Skypoint |
| Shockwave Medical, INC | $2,334.44 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $1,867.95 | 2021-2025 | Avvigo Guidance System, Rotapro, Watchman Flx |
| Medtronic, INC. | $997.59 | 2022-2023 | Corevalve Evolut R, Onyx Frontier |
| Biotronik INC. | $980.14 | 2021-2023 | Orsiro Mission, Nhancer Rx, Recross |
| Acist Medical Systems, INC. | $897.72 | 2021-2023 | |
| Abiomed | $847.30 | 2022-2024 | Impella |
| Cardiovascular Systems INC. | $732.57 | 2021-2023 | Diamondback Coronary, Diamondback Peripheral |
| Chiesi USA, INC. | $483.12 | 2022-2023 | Kengreal, Cleviprex |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $407.79 | 2023-2025 | Lifevest |
| Philips North America LLC | $308.18 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $283.93 | 2021-2025 | Farxiga, Andexxa, Brilinta |
| Inari Medical, INC. | $275.52 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $243.75 | 2019-2025 | Repatha, Repatha |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $225.36 | 2020-2024 | Xarelto |
| W. L. Gore & Associates, INC. | $189.18 | 2022-2023 | Gore Cardioform Septal Occluder |
| Jenavalve Technology, INC. | $185.13 | 2021 | |
| Novartis Pharmaceuticals Corporation | $153.86 | 2023-2024 | |
| Teleflex LLC | $152.80 | 2022 | |
| Terumo Medical Corporation | $143.13 | 2022 | |
| Merck Sharp & Dohme LLC | $93.15 | 2024-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.71 | 2023-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $75.36 | 2020-2025 | Eliquis, Camzyos |
| Lantheus Medical Imaging, INC. | $67.71 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.74 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $33.03 | 2024 | Evkeeza |
| Pfizer INC. | $28.36 | 2025 | |
| Kestra Medical Technology Services, INC. | $28.12 | 2024-2025 | Assure Wcd |
| Getinge USA Sales, LLC | $25.82 | 2023 | Cardiosave Hybrid, Type B Plug |
| Grifols USA, LLC | $24.99 | 2024 | Hyperrab |
| Actelion Pharmaceuticals US, INC. | $24.78 | 2023 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Healy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.